Beta Bionics chief commercial officer Mark Hopman reports sale of $6,253 in common shares
BBNX•Beta Bionics Chief Commercial Officer Mark Hopman sold 370 shares on Nov. 2, 2026, at $16.90 each, for $6,253. His direct ownership totaled 54,143 shares after the sale.
1. Share sale
Mark Hopman, Beta Bionics’ chief commercial officer, sold 370 common shares on Nov. 2, 2026, at $16.90 per share. He directly owned 54,143 shares following the sale.
